{"data":{"id":"us-ut/utah-code-26b-4-513","jurisdiction":"us-ut","citation":"Utah Code § 26B-4-513","heading":"Coprescription guidelines.","body":"(1) As used in this section:\n(a) \"Controlled substance prescriber\" means the same as that term is defined in Section 58-37-303.\n(b) \"Coprescribe\" means to issue a prescription for an opiate antagonist with a prescription for an opiate.\n(2) The department shall, in consultation with the Medical Licensing Board created in Section 58-67-201, and the Division of Professional Licensing created in Section 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, scientifically based guidelines for controlled substance prescribers to coprescribe an opiate antagonist to a patient.","path":["Title 26B Utah Health and Human Services Code","Chapter 26B-4 Health Care - Delivery and Access","Part 26B-4-5 Treatment Access"],"source_url":"https://le.utah.gov/xcode/Title26B/Chapter4/26B-4-S513.html","current_through":"2026 General Session","vintage":"","retrieved_at":"2026-09-03T11:34:33Z","sha256":"b3a897628f56c8bd3d6e33c55ff2b69b9b01ad96c116073d7c762abcc655a77d","source_id":"us-ut","stale":false,"prev":"us-ut/utah-code-26b-4-512","next":"us-ut/utah-code-26b-4-514"},"notice":"GroundRules: Original legal text. Not legal advice."}